MedTrace Logo

CorPath® GRX Neuro Study

NCT04236856 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2025-03-06

Study results available
· View outcomes & findings →

Summary

The primary objective of this study is to evaluate the effectiveness and safety of robotic-assisted endovascular embolization procedures compared to objective performance criteria for traditional, manual operation based on the scientific literature.

Conditions

  • Intracranial Aneurysm
  • Subarachnoid Hemorrhage
  • Headache

Interventions

DEVICE

Robotic Endovascular Procedure

After providing written informed consent, subjects with cerebral aneurysms may have their aneurysm treated using the CorPath GRX System.

Sponsors & Collaborators

  • Corindus Inc.

    lead INDUSTRY

Principal Investigators

  • Michel Piotin, MD, PhD · Interventional Neuroradiologisit & Director, Foundation Rothschild

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-08-21
Primary Completion
2022-04-23
Completion
2022-10-12

Countries

  • Australia
  • Austria
  • Canada
  • France
  • Spain
  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04236856 on ClinicalTrials.gov